Redox Signaling and the Control of Cell Growth and Death

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 329-359

  Powis, Garth ^a   Gasdaska, John R ^a   Baker, Amanda ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011825635     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60990-4     Document Type: Article

References (204)

1. Abate C., Patel L., Rauscher III F.J., and Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249 (1990) 1157-1161
2. Adcock I.M., Brown C.R., Kwon O., and Barnes P.J. Oxidative stress induces NFKB DNA binding and inducible nos mRNA in human epithelial cells. Biochem. Biophys. Res. Commun. 199 (1994) 1518-1524
3. Ammendola R., Fiore F., Esposito F., Caserta G., Mesuraca M., Russo T., and Cimino F. Differentially expressed mRNA as a consequence of oxidative stress in intact cells. FEBS Lett. 371 (1995) 209-213
4. Amstad P.A., Krupitza G., and Cerutti P.A. Mechanism of c-fos induction by active oxygen. Cancer Res. 52 (1992) 3952-3960
5. Aslund F., Ehn B., Miranda-Vizuete M., Pueyo C., and Holmgren A. Two additional glutaredoxins exist in Escherichia coli: Glutaredoxin 3 is a hydrogen donor for ribonucleotide reductase in a thioredoxidglutaredoxin 1 double mutant. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9813-9817
6. Babson J.R., Abell N.S., and Reed D.J. Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes. Biochem. Pharmacol. 30 (1981) 2299-2304
7. Baker A.F., Briehl M.M., Dorr R., and Powis G. Decreased antioxidant defense and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 selectively prevents the loss of catalase activity. Cell Death Differ. 3 (1996) 207-213
8. Bauman J.W., Liu L., Liu Y.P., and Klaassen C.D. Increase in metallothionein production by chemicals that induce oxidative stress. Toxicol. Appl. Pharmacol. 110 (1991) 347-354
9. Beck I., Weinmann R., and Caro J. Characterisation of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-kD nuclear DNA-binding protein in erythropoietin-producing and non producing cells. Blood 82 (1993) 704-711
10. Bedi A., Pasricha P.J., Akhtar A.J., Barber J.P., Bedi G.C., Giardiello F.M., Zehnbauer B.A., Hamilton S.R., and Jones R.J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55 (1995) 1811-1816
11. Bergelson S., Pinkus R., and Daniel V. Intracellular glutathione levels regulate fos/jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54 (1994) 36-40
12. Bhimani R.S., Troll W., Grunberger D., and Frenkel K. Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res. 53 (1993) 4528-4533
13. Biguet C., Wakasugi N., Mishal Z., Holmgren A., Chouaib S., Tursz T., and Wakasugi H. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J. Biol. Chem. 269 (1994) 28865-28870
14. Bodenstein J., and Follmann H. Characterization of two thioredoxins in pig heart including a new mitochondrial protein. Z. Naturforsch. 46c (1991) 270-279
15. Bodenstein-Lang J., Buch A., and Follmann H. Animal and plant mitochondria contain specific thioredoxins. FEBS Lett. 258 (1989) 22-26
16. Bohmann D., Bos T.J., Admon A., Nishimura T., Vogt P.K., and Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-I. Science 238 (1987) 1386-1392
17. Boniface J.J., and Reichert Jr. L.E. Evidence for a novel thioredoxin-like catalytic property of gonadotropic hormones. Science 247 (1990) 61-64
18. Briehl M.M., Cotgreave I.A., and Powis G. Downregulation of the antioxidant defense during glucocorticoid-mediated apoptosis. Cell Death Differ. 2 (1995) 41-46
19. Brookens M.A., Lazo J.S., Yalowich J.C., Allen W.P., and Whitmore M. Metallothionein reduces the cytotoxicity and DNA damaging effects of nitric oxide. Proc. Natl. Acad. Sci. U.S.A. (1995) in press.
20. Broome J.D., and Jeng M.W. Promotion of replication in lymphoid cells by specific thiols and disulfides in vitro. J. Exp. Med. 138 (1973) 574-592
21. Brouwer M., Hoexum-Brouwer T., and Cashon R.E. A putative glutathione-binding site in CdZn-metallothionein identified by equilibrium binding and molecular-modeling studies. Biochem. J. 294 (1993) 219-225
22. Burdon R.H., and Gill V. Cellularly generated active oxygen species and HeLa cell proliferation. Free Rad. Res. Commun. 19 (1993) 203-213
23. Buttke T.M., and Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol. Today 15 (1994) 7-10
24. Chang D.J., Ringold G.M., and Heller R.A. Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem. Biophys. Res. Commun. 188 (1992) 538-546
25. Chen Y., and Chan T.M. Orthovanadate and 2,3-dimethoxy-1,4-naphrhoquinone augment growth factor-induced cell proliferation and c-fos gene expression in 3T3-L1 cells. Arch. Biochem. Biophys. 305 (1993) 9-16
26. Chen Y., Yang D.-C., Brown A.B., Jeng Y., Tatoyan A., and Chan T.M. Activation of a membrane-associated phosphatidylinositol kinase through tyrosine-protein phosphorylation by naphthoquinones and orthovanadate. Arch. Biochem. Biophys. 283 (1990) 184-192
27. Cho Y., Gorina S., Jeffrey P.D., and Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265 (1994) 346-354
28. Clarke F.M., Orozco C., Perkins A.V., Cock I., Tonissen K.F., Robins A.J., and Wells J.R. Identification of molecules involved in the "early pregnancy factor" phenomenon. J. Reprod. Fertil. 93 (1991) 525-539
29. Clive D.R., and Greene J.J. Association of protein disulfide isomerase activity and the induction of contact inhibition. Exp. Cell Res. 214 (1994) 139-144
30. Cohen J.J. Apoptosis. Immunol. Today 14 (1993) 126-130
31. Conley R.R., and Pigiet V. In vivo distribution of phosphothioredoxin and thioredoxin in Escherichia coli. J. Biol. Chem. 253 (1978) 5568-5572
32. Cotgreave I.A., Weis M., Atzori L., and Moldeus P. Glutathione and protein function. In: Vina J. (Ed). "Glutathione: Metabolism and Physiolgical Funtion" (1994), CRC Press, Boca Raton, FL 155-175
33. Darr D., and Fridovich I. Irreversible inactivation of catalase by 3-amino-1,2,4-triazole. Biochem. Pharmacol. 35 (1986) 3642
34. Datta R., Taneja K., Sukhatme V.P., Qureshi S.A., Weichselhaum R., and Kufe D.W. Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2419-2422
35. Deiss L.P., and Kimchi A. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252 (1991) 117-120
36. Delaney J.M., and Georgopoulos C. Physical map locations of the trxB, htrD, cydC, and cydD genes of. Escherichia coli. J. Bacteriol. 174 (1992) 3824-3825
37. Deng H.-X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.-Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewell R.A., Pericak-Vance M.A., and Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261 (1993) 1047-1051
38. Dyson H.J., Gippert G.P., Case D.A., Holmgren A., and Wright P.E. Three-dimensional solution structure of the reduced form of Escherichia coli thioredoxin determined by nuclear magnetic resonance spectroscopy. Biochemistry 29 (1990) 4129-4136
39. Ebadi M., and Iversen P.L. Metallothionein in carcinogenesis and cancer chemotherapy. Gen. Pharmacol. 25 (1994) 1297-1310
40. Edman J.C., Ellis L., Blacher R.W., Roth R.A., and Rutter W.J. Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 317 (1985) 267-270
41. Ericson M.L., Hörling J., Wendel-Hansen V., Holmgren A., and Rosen A. Secretion of thioredoxin after in vitro activation of human B cells. Lympbokine Cytokine Res. 11 (1992) 201-207
42. Fanger M.W., Hart D.A., Wells J.V., and Nisonoff A. Enhancement by reducing agents of the transformation of human and rabbit peripheral lymphocytes. J. Immunol. 105 (1970) 1043-1045
43. Farquhar R., Homey N., Murant S.J., Bossier P., Schultz L., Montgomery D., Ellis R.W., Freedman R.B., and Tuite M.F. Protein disulfide isomerase is essential for viability in. Saccharomyces cerevisiae. Gene 108 (1991) 81-89
44. Forman-Kay J.D., Clore G.M., and Gronenborn A.M. Relationship between electrostatics and redox function in human thioredoxin: Characterization of pH titration shifts using two-dimensional homo- and heteronuclear NMR. Biochemistry 31 (1992) 3442-3452
45. Forster S.J., and Freedman R.B. Catalysis by protein disulphide-isomerase of the assembly of trimeric procollagen from procollagen polypoptide chains. Biosci. Rep. 4 (1984) 223-229
46. Fountoulakis M. Unfolding intermediates of the extracellular domain of the interferon gamma receptor. J. Biol. Chem. 267 (1992) 7095-7100
47. Freedman R.B., Hirst T.R., and Tuite M.F. Protein disulphide isomerase: Building bridges in protein folding. Trends Biochem. Sci. 19 (1994) 331-336
48. Galter D., Mihm S., and Dröge W. Distinct effects of glutathione disulfide on the nuclear transcription factors KB and the activator protein-1. Eur. J. Biochem. 221 (1994) 639-648
49. Gasdaska J.R., Berggren M., and Powis G. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ. 6 (1995) 1643-1650
50. Gasdaska P.Y., Gasdaska J.R., Cochran S., and Powis G. Cloning and sequencing of human thioredoxin reductase. FEBS Lett. 373 (1995) 5-9
51. Gasdaska P.Y., Oblong J.E., Cotgreave I.A., and Powis G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): Thioredoxin mRNA is elevated in some human tumors. Biochim. Biophys. Acta 1218 (1994) 292-296
52. Gleason F.K., Lim C.-J., Gerami-Nejad M., and Fuchs J.A. Characterization of Escherichia coli thioredoxins with altered active site residues. Biochemistry 29 (1990) 3701-3709
53. Grasso P., Crabb J.W., and Reichert Jr. L.E. An explanation for the disparate effects of synthetic peptides corresponding to human follicle-stimulating hormone beta-subunit receptor binding regions (33-53) and (81-95) and their serine analogs on steriodo-genesis in cultured rat Sertoli cells. Biochem. Biophys. Res. Commun. 190 (1993) 56-62
54. Greene J.J., and Brophy C.I. Induction of protein disulfide isomerase during proliferation arrest and differentiation of SHSY neuroblastoma cells. Cell. Mol. Biol. 41 (1995) 473-480
55. Greenspan H.C., and Aruoma O.I. Oxidative stress and apoptosis in HIV infection: A role for plant-derived metabolites with synergistic antioxidant activity. Immunol. Today 15 (1994) 209-213
56. Grippo J.F., Tienrungroj W., Dahmer M.K., Housley P.R., and Pratt W.B. Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin. J. Biol. Chem. 258 (1983) 13658-13664
57. Hainaut P., and Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53 (1993) 4469-4473
58. Hainaut P., Rolley N., Davies M., and Milner J. Modulation by copper of p53 conformation and sequence-specific DNA binding: Role for Cu(II)/Cu(I) redox mechanism. Oncogene 10 (1995) 27-32
59. Hatala M.A., Dipippo V.A., and Powers C.A. Biological thiols elicit prolactin proteolysis by glandular kallikrein and permit regulation by biochemical pathways linked to redox control. Biochemistry 30 (1991) 7666-7672
60. Hayashi T., Ueno Y., and Okamoto T. Oxidoreductive regulation of nuclear factor K B. J. Biol. Chem. 268 (1993) 11380-11388
61. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., and Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91 (1995) 3270-3274
62. Hewllet G., Opitz H.G., Schlumberger H.D., and Lemke H. Growth regulation of a murine lymphoma cell line by a 2-mercaptoethanol or macrophage-activated serum factor. Eur. J. Immunol. 7 (1977) 781-785
63. Hickman J.A., Potten C.S., Merritt A.J., and Fisher T.C. Apoptosis and cancer chemotherapy. Philos. Trans. R. Soc. Lond. Series B: Biol. Sci. 345 (1994) 319-325
64. Higgins K.A., Perez J.R., Coleman T.A., Dorshkind K., Mccomas W.A., Sarmiento U.M., Rosen C.A., and Narayanan R. Antisense inhibition of the p65 subunit of NF-KB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9901-9905
65. Hockenberry D.M., Oltvai Z.N., Yin X.-M., Millirnan C.L., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
66. Hollingsworth R.E., and Lee W.-H. Tumor suppressor genes: New prospects for cancer research. J. Natl. Cancer Inst. 83 (1991) 91-96
67. Holmgren A. Hydrogen donor system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 2275-2279
68. Holmgren A. Glutaredoxin: Structure and function. In: Vina J. (Ed). "Glutathione: Metabolism and Physiological Function" (1990), CRC Press, Boca Raton, FL 145
69. Holmgren A., and Luthman M. Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry 17 (1978) 4071-4077
70. Hopper S., and Iurlano D. Properties of a thioredoxin purified from rabbit bone marrow which fails to serve as a hydrogen donor for the homologous ribonucleotide reductase. J. Biol. Chem. 258 (1983) 13453-13457
71. Hori K., Katayama M., Sato N., Ishii K., Waga S., and Yodoi J. Neuroprotection by glial cells through adult T cell leukemia-derived factorhuman thioredoxin (ADF/TRX). Brain Res. 652 (1994) 304-310
72. Huang R.-P., and Adamson E.D. Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: Evidence for modulation by a redox mechanism. DNA. Cell Biol. 12 (1993) 265-273
73. Hwang C., Sinskey A.J., and Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257 (1992) 1496-1502
74. Ifversen P., Zhang X.M., Ohlin M., Zeuthen J., and Borrebaeck C.A. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines. Hum. Antibodies Hybridomas 4 (1993) 115-123
75. Ireland R.C., Li S.-Y., and Dougherty J.J. The DNA binding of purified Ah receptor heterodimer is regulated by redox conditions. Arch. Biochem. Biophys. 319 (1995) 470-480
76. Israel N., Gougerot-Pocidalo M.A., Aillet F., and Virelizier J.L. Redox status of cells influences constitutive or induced NF-KB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149 (1992) 3386-3393
77. Jacobson M.D., and Raff M.C. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374 (1995) 814-816
78. Jewell S.A., Bellomo G., Thor H., Orrenius S., and Smith M. Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. Science 217 (1982) 1257-1259
79. Kaghad M., Dessarps F., Jacquemin-Sablon H., Caput D., Fradelizi D., and Wollman E.E. Genomic cloning of human thioredoxin-encoding gene: Mapping of the transcription start point and analysis of the promoter. Gene 140 (1994) 273-278
80. Kallis G.B., and Holmgren A. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from. Escherichia coli. J. Biol. Chem. 255 (1980) 10261-10265
81. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., örd T., and Bredesen D.E. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262 (1993) 1274-1277
82. Kerr J.F.R., Winterford C.M., and Harmon B.V. Apoptosis: Its significance in cancer and cancer therapy. Cancer 73 (1994) 2013-2026
83. Kistner A., Sanders D., and Habermann E. Disulfide formation in reduced tetanus toxin by thioredoxin: The pharmacological role of interchain covalent and noncovalent bonds. Toxicon. 31 (1993) 1423-1434
84. Koong A.C., Chen E.Y., and Giaccia A.J. Hypoxia causes the activation of nuclear factor KB through the phosphorylation of IKBα on tyrosine residues. Cancer Res. 54 (1994) 1425-1430
85. Koropatnick J., Leibbrandt M., and Cherian M.G. Organ-specific metallothionein induction by X-irradiation. Radiat. Res. 119 (1989) 356-365
86. Korsmeyer S.J. Bcl-2: An antidote to programmed cell death. Cancer Surv. 15 (1992) 105-118
87. Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80 (1992) 879-886
88. Kosower N.S., and Kosower E.M. The glutathione status of cells. Int. Rev. Cytol. 54 (1978) 109-160
89. Krause G., Lundström J., Barea L., and Pueyo De La Cuesta C. Mimicking the active site of protein disulfide-isomerase by substitution of proline 34 in Escherichia coli thioredoxin. J. Biol. Chem. 266 (1991) 9494-9500
90. Lafage-Pochitaloff-Huvale M., Shaw A., Dessarps F., Mannoni D., Fradelizi D., and Wollman E.E. The gene for human thioredoxin maps on the short arm of chromosome 3 at bands 3p11-p12. FEBS Lett. 255 (1987) 89-91
91. ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270 (1995) 21195-21198
92. Lash L.H., Hagen T.M., and Jones D.P. Exogenous glutathione protects intestinal epithelial cells from oxidative injury. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4641-4645
93. Laurent T.C., Moore E.C., and Reichard P. Enzymatic synthesis of deoxyribonucleotides. VI. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem. 239 (1964) 3436-3444
94. Lee S.-H., Fujita N., Imai K., and Tsuruo T. Cysteine produced from lymph node stromal cells suppresses apoptosis of mouse malignant T-lymphoma cells. Biochem. Biophys. Res. Commun. 213 (1995) 837-844
95. Lennon S.V., Martin S.J., and Cotter T.G. Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell. Prolif. 24 (1991) 203-214
96. Levy E.J., Anderson M.E., and Meister A. Transport of glutathione diethyl ester into human cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9171-9175
97. Liang C.-M., Lee N., Cattell D., and Liang S.-M. Glutathione regulates interleukin-2 activity on cytotoxic T cells. J. Biol. Chem. 264 (1989) 13519-13523
98. Liang S.-M., Thatcher D.R., Liang C.-M., and Bernard A. Studies of structure-activity relationships of human interleukin-2. J. Biol. Chem. 261 (1986) 334-337
99. Lopez-Barea J., Barcena J.A., Bocanegra J.A., Florindo J., Garcia-Alfonso C., Lopez-Ruiz A., Martinez-Galisteo E., and Peinado J. Structure, mechanism, functions, and regulatory properties of glutathione reductase. In: Vina J. (Ed). "Metabolism and Physiological Function" (1990), CRC Press, Boca Raton, FL 105
100. Lozano R.M., Yee B.C., and Buchanan B.B. Thioredoxin-linked reductive inaaivation of venom neurotoxins. Arch. Biochem. Biophys. 309 (1994) 356-362
101. Luna M.C., Wong S., and Gomer C.J. Photodynamic therapy mediated induction of early response genes. Cancer Res. 54 (1994) 1374-1380
102. Lundström J., and Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J. Biol. Chem. 265 (1990) 9114-9120
103. Lundström J., Krause G., and Holmgren A. A Pro to His mutation in active site of thioredoxin increases its disulfide-isomerase activity 10-fold: New refolding systems for reduced or randomly oxidized ribonuclease. J. Biol. Chem. 267 (1992) 9047-9052
104. Martin S.J., and Green D.R. Protease activation during apoptosis: Death by a thousand cuts?. Cell 82 (1995) 349-352
105. Martinez-Galisteo F., Padilla C.A., Garcia-Alfonso C., Lopez-Barea J., and Barcena J.A. Purification and properties of bovine thioredoxin system. Biochimie 75 (1993) 803-809
106. Masutani H., Naito M., Takahashi K., Hattori T., Koito A., Takatsuki K., Go T., Nakamura H., Fujii S., Yoshida Y., Okuma M., and Yodoi J. Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: Loss of ADF high-producer cells in lymphoid tissues of AIDS patients. AIDS Res. Hum. Retrovir. 8 (1992) 1707-1715
107. Matsuda M., Masutani H., Nakamura H., Miyajima S., Yamauchi A., Yonehara S., Uchida A., Irimajiri K., Horiuchi A., and Yodoi J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147 (1991) 3837-3841
108. Matthews J.R., Wakasugi N., Virelizier J.-L., Yodoi J., and Hay R.T. Thioredoxin regulates the DNA binding activity of NF-KB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20 (1992) 3821-3830
109. Mau B.-L., and Powis G. Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds. Biochem. Pharmacol. 43 (1992) 1613-1620
110. Mcbride A.A., Klausner R.D., and Howley P.M. Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7531-7535
111. Mcdonnell T.J., Marin M.C., Hsu B., Brisbay S.M., Mcconnell K., Tu S.-M., Campbell M.L., and Rodriguez-Villanueva J. Symposium: Apoptosis/programmed cell death. Radiat. Res. 136 (1993) 307-312
112. Mcdonnell T.J., Meyn R.E., and Robertson L.E. Implications of apoptotic cell death regulation in cancer therapy. Sem. Cancer Biol. 6 (1995) 53-60
113. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263 (1988) 17205-17208
114. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: Applications in research and therapy. Pharmacol. Ther. 51 (1991) 155-194
115. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 54 (1994) 1969s-1975s
116. Mello-Filho A.C., Chubatsu L.S., and Meneghini R. Chinese hamster cells rendered resistant to high cadmium concentrations also become resistant to oxidative stress. Biochem. J. 256 (1988) 475-479
117. Meyer M., Schreck R., and Baeuerle P.A. H2O2 and antioxidants have opposite effects on activation of NF-KB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12 (1993) 2005-2015
118. Miranda-Vizuete A., Martinez-Galisteo E., Aslund F., Lopez-Barea J., Pueyo C., and Holmgren A. Null thioredoxin and glutaredoxin Escherichia coli K-12 mutants have no enhanced sensitivity to mutagens due to a new GSH-dependent hydrogen donor and high increases in ribonucleotide reductase activity. J. Biol. Chem. 269 (1994) 16631-16637
119. Mizunaga T., Katakura Y., Miura T., and Maruyama Y. Purification and characterization of yeast protein disulfide isomerase. J. Biochem. 108 (1990) 846-851
120. Morrow C.S., and Cowan K.H. Glutathione S-transferases and drug resistance. Cancer Cells 2 (1990) 15-22
121. Muller E.G. Thioredoxin genes in Saccharomyces cerevisiae: Map positions of TRX1 and TRX2. Yeast 8 (1992) 117-120
122. Muller E.G.D. Thioredoxin deficiency in yeast prolongs S phase and shortens the GI interval of the cell cycle. J. Biol. Chem. 266 (1991) 9194-9202
123. Nakamura H., Masutani H., Tagaya Y., Yamauchi A., Inamoto T., Nanbu Y., Fujii S., Ozawa K., and Yodoi J. Expression and growth-promoting effect of adult T-cell leukemia-derived factor: A human thioredoxin homologue in hepatocellular carcinoma. Cancer 69 (1992) 2091-2097
124. Nose K., Shibanuma M., Kikuchi K., Kageyama H., Sakiyama S., and Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem. 201 (1991) 99-106
125. Oberley T.D., Schultz J.L., Li N., and Oberley L.W. Antioxidant enzyme levels as a function of growth state in cell culture. Free Rad. Biol. Med. 19 (1995) 53-65
126. Oblong J.E., Gasdaska P.Y., Sherrill K., and Powis G. Purification of human thioredoxin reductase: Properties and characterization by absorption and circular dichroism spectroscopy. Biochemistry 32 (1993) 7271-7277
127. Oblong J.E., Berggren M., Gasdaska P.Y., and Powis C. Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors ot human thioredoxin reductase and elimination of mitogenic properties of thioredoxin. J. Biol. Chem. 269 (1994) 11714-11720
128. Oblong J.E., Berggren M., Gasdaska P.Y., Hill S.R., and Powis G. Site-directed mutagenesis of Lys36 in human thioredoxin: The highly conserved residue affects the efficiency of reduction and growth stimulation but is not essential for the redox protein's biochemical and biological properties. Biochemistry 34 (1995) 3319-3324
129. Ohba M., Shibanuma M., Kuroki T., and Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell Biol. 126 (1994) 1079-1088
130. Okuno H., Akahori A., Sato H., Xanthoudakis S., Curran T., and Iba H. Escape from redox regulation enhances the transforming activity of Fos. Oncogene 8 (1993) 695-701
131. Pickett C.B., and Lu A.Y.H. Glutathione S-transferases: Gene structure, regulation, and biological function. Annu. Rev. Biochem. 58 (1989) 743-764
132. Pihlajaniemi T., Helaakoski T., Tasanen K., Myllyla R., Huhtala M.L., Koivu J., and Kivirikko K.I. Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. EMBO J. 6 (1987) 643-649
133. Powis G., Briehl M., and Oblong J. Redox signalling and the control of cell growth and death. Pharmacol. Ther. 68 (1995) 149-173
134. Prongay A.J., Engelke D.R., and Williams Jr. C.H. Characterization of two active site mutations of thioredoxin reductase from. Escherichia coli. J. Biol. Chem. 264 (1989) 2656-2664
135. Raff M.C. Social controls on cell survival and cell death. Nature 356 (1992) 397-400
136. Rainwater R., Parks D., Anderson M.E., Tegtmeyer P., and Mann K. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 15 (1995) 3892-3903
137. Rao G.N., and Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circulat. Res. 70 (1992) 593-599
138. Rao G.N., Lassègue B., Griendling K.K., and Alexander R.W. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: Role of arachinoid acid. Oncogene 8 (1993) 2759-2764
139. Reed D.J. Regulation of reductive processes by glutathione. Biochem. Pharmacol. 35 (1986) 7-13
140. Ren X., Bjornstedt M., Shen B., Ericson M.L., and Holmgren A. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochem. 32 (1993) 9701-9705
141. Rubartelli A., Bajetto A., Allavena G., Wollman E., and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267 (1992) 24161-24164
142. Rubartelli A., Bonifaci N., and Sitia R. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res. 55 (1995) 675-680
143. Russel M., and Holmgren A. Construction and characterization of glutaredoxin-negative mutants of. Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 990-994
144. Russel M., and Holmgren A. Thioredoxin or glutaredoxin in Eshcerichia coli is essential for sulfate reduction but not for deoxyribonucleotide synthesis. J. Bacteriol. 172 (1990) 1923-1929
145. Russel M., and Model P. Direct cloning of the trxB gene that encodes thioredoxin reductase. J. Bacteriol. 163 (1985) 238-242
146. Russel M., and Model P. Sequence of thioredoxin reductase from. Escherichia coli. J. Biol. Chem. 263 (1988) 9015-9019
147. Salz H.K., Flickinger T.W., Mittendorf E., Pellicena-Palle A., Petschek J.P., and Albrecht E.B. The drosophila maternal effect locus deadhead encodes a thioredoxin homolog required for female meiosis and early embryonic development. Genetics 136 (1994) 1075-1086
148. Sandstrom P.A., and Buttke T.M. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4708-4712
149. Sandstrom P.A., Tebbey P.W., Van Cleave S., and Buttke T.M. Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. J. Biol. Chem. 269 (1994) 798-801
150. Sato M., and Bremner I. Oxygen free radicals and metallothionein. Free Rad. Biol. Med. 14 (1993) 325-337
151. Schallreuter K.U., Gleason F.K., and Wood J.M. The mechanism of action of the nitrosoureas anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim. Biophys. Acta 1054 (1990) 14-20
152. Schenk H., Klein M., Erdbrügger W., Dröge W., and Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-KB and AP-1. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1672-1676
153. 2+ signals. J. Biol. Chem. 268 (1993) 16688-16692
154. Schlager J.J., Hoerl B.J., Riebow J., Scott D.P., Gasdaska P., Scott R.E., and Powis G. Increased NADPH:(quinone-acceptor) oxidoreductase (DT-diaphorase) activity is associated with density dependent growth inhibition of normal but not transformed cells. Cancer Res. 53 (1993) 1338-1342
155. Schwartz L.M., Smith S.W., Jones M.E.E., and Osborne B.A. Do all programmed cell deaths occur via apoptosis?. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 980-984
156. Semenza G.L., Roth P.H., Frang H., and Wang G.L. Transcriptional regulation of genes encoding glycoylytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269 (1994) 23757-23763
157. Shibanuma M., Kuroki T., and Nose K. Inhibition of N-acetyl-L-cysteine of interleu-kin-6 mRNA induction and activation of NFKB by tumor necrosis factor a in a mouse fibroblastic cell line, Balb/3T3. FEBS Lett. 353 (1994) 62-66
158. Sorachi K.-I., Sugie K., Maekawa N., Takami M., Kawabe T., Kumagai S., Imura H., and Yodoi J. Induction and function of FcERII on YT cells; possible role of ADF/thioredoxin in FcERII expression. Immunobiology 185 (1992) 193-206
159. Staal F.J., Roederer M., and Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor K-B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9943-9947
160. Staal F.J.T., Roederer M., Israelski D.M., Bubp J., Mole L.A., Mcshane D., Deresinski S.C., Ross W., Sussman H., Raju P.A., Anderson M.T., Moore W., Ela S.W., Herzenberg L.A., and Herzenberg L.A. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res. Hum. Retrovir. 8 (1992) 305-311
161. Stefanelli C., Stanic I., Bonavita F., Muscari C., Pignatti C., Rossoni C., and Caldarera C.M. Oxygen tension influences DNA fragmentation and cell death in glucocorti-coid-treated thymocytes. Biochem. Biophys, Res. Commun. 212 (1995) 300-306
162. Storz B., Tarraglia L.A., and Ames B.N. Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation. Science 248 (1990) 189-194
163. Storz G., Tartaglia L.A., Farr S.B., and Ames B.N. Bacterial defenses against oxidative stress. Trends Genet. 6 (1990) 363-368
164. Sundaresan M., Yu Z.-X., Ferrans V.J., Irani K., and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
165. Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K.-I., Yokota T., Wakasugi H., and Yodoi J. ATL-derived factor (ADF), an IL-2 receptormac inducer homologous to thioredoxin: Possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 8 (1989) 757-764
166. Tagaya Y., Okada M., Sugie K., Kasahara T., Kondo N., Hamuro J., Matsushima K., Dinarello C.A., and Yodoi J. IL-2 receptor(p55)/TAC-inducing factor purification and characterization of adult T cell leukemia-derived factor. J. Immunol. 140 (1988) 2614-2620
167. Taketo M., Matsui M., Rochelle J.M., Yodoi J., and Seldin M.F. Mouse thioredoxin gene maps on chromosome 4, whereas its pseudogene maps on chromosome 1. Genomics 21 (1994) 251-253
168. Thelander L. Thioredoxin reductase: Characterization of a homogenous preparation from. Escherichia coli B. J. Biol. Chem. 242 (1967) 852-859
169. Thomas J.P., Bachowski G.J., and Girotti A.W. Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothionein. Biochim. Biophys. Acta 884 (1986) 448-461
170. Thornalley P.J., and Vasak M. Possible role for metallothionein in protection against radiation-induced oxidative stress: Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta 827 (1985) 36-44
171. Tolendano M.B., and Leonard W.J. Modulation of transcription factor NF-KB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4328-4332
172. Tomimoto H., Akiguchi I., Wakita H., Kimura J., Hori K., and Yodoi J. Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res. 625 (1993) 1-8
173. Tonissen K., Wells J., Cock I., Perkins A., Orozco C., and Clarke F. Site-directed mutagenesis of human thioredoxin: Identification of cysteine 74 as critical to its function in the "early pregnancy factor" system. J. Biol. Chem. 268 (1993) 22485-22489
174. Tonissen K.F., and Wells J.R.E. Isolation and characterization of human thioredoxin-encoding genes. Gene 102 (1991) 221-228
175. Vaux D.L., Haecker G., and Strasser A. An evolutionary perspective on apoptosis. Cell 76 (1994) 777-779
176. Veness-Meehan K.A., Cheng E.R.Y., Mercier C.E., Blixt S.L., Johnston C.J., Watkins R.H., and Horowitz S. Cell-specific alterations in expression of hyperoxia-induced mRNAs of lung. Am. J. Respir. Cell Mol. Biol. 5 (1991) 516-521
177. Wakasugi N., Tagaya Y., Wakasugi A., Mitsui M., Maeda M., Yodoi J., and Tursz T. Adult T-cell leukemia-derived factor/Thioredoxin produced by both human T-lymphotropic virus type 1 and Epstein-Barr virus-transformed lymphocytes acts as an autocrine growth factor and synergized with interleukin-1 and interleukin-2. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 8282-8286
178. Waksman G., Krishna T.S.R., Williams Jr. C.H., and Kuriyan J. Crystal structure of Escherichia coli thioredoxin reductase at 2 Å resolution. J. Mol. Biol. 236 (1994) 800-816
179. Walker L.J., Craig R.B., Harris A.L., and Hickson I.D. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res. 22 (1994) 4884-4889
180. Walker L.J., Robson C.N., Black E., Gillespie D., and Hickson I.D. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DAN binding. Mol. Cell. Biol. 13 (1993) 5370-5379
181. Wang C.C., and Tsou C.L. Protein disulfide isomerase is both an enzyme and a chaperone. FASEB J. 7 (1993) 1515-1517
182. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor-1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4303-4308
183. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor-1 and regulation of DNA-binding activity by hypoxia. J. Biol. Chem. 268 (1993) 21513-21518
184. Wang G.L., and Semenza G.L. Purification and characterisation of hypoxia inducible factor-1. J. Biol. Chem. 270 (1995) 1230-1237
185. Wasylyk C., and Wasylyk B. Oncogenic conversion of Ets affects redox regulation in-vivo and in-vitro. Nucleic Acids Res. 21 (1993) 523-529
186. Weckbecker G., and Cory J.G. Ribonucleotide reductase activity and growth of glutathione-depleted mouse leukemia L1210 cells in vitro. Cancer Lett. 40 (1988) 257-264
187. Wells W.W., Xu D.P., Yang Y.F., and Rocque P.A. Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J. Biol. Chem. 265 (1990) 15361-15364
188. Wells W.W., Yang Y., Deits T.L., and Gan Z.R. Thioltransferases. Adv. Enzym. Rel. Areas Mol. Biol. 66 (1993) 149-201
189. Wettrau J.R., Aggerbeck L.P., Laplaud P.M., and Mclean L.R. Structural properties of the microsomal triglyceride-transfer protein complex. Biochemistry 30 (1991) 4406-4412
190. Williams G.T. Apoptosis in the immune system. J. Pathol. 173 (1994) 1-4
191. Williamson J.M., Boettcher B., and Meister A. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 6246-6249
192. Winkler B.S., Orselli S.M., and Rex T.S. The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective. Free Rad. Biol. Med. 17 (1994) 333-349
193. Wollman E.E., D'Auriol L., Rimsky L., Shaw A., Jacquot J.-P., Wingfield P., Graber P., Dessarps F., Robin P., Galibert F., Bertoglio J., and Fradelizi D. Cloning and expression of cDNA for human thioredoxin. J. Biol. Chem. 263 (1988) 15506-15512
194. Wunderlich M., and Glockshuber R. In vivo control of redox potential during protein folding catalyzed by bacterial protein disulfide-isomerase (DsbA). J. Biol. Chem. 268 (1993) 24547-24550
195. Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metast. Rev. 11 (1992) 95-103
196. Xanthoudakis S., Miao G., Wang F., Pan Y.-C.E., and Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11 (1992) 3323-3335
197. Xanthoudakis S., Miao G.G., and Curran T. The redox and DNA-repair activities of ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 23-27
198. Xia T.H., Bushweller J.H., Sodano P., Billeter M., Bjornberg O., Holmgren A., and Wuthrich K. NMR structure of oxidized Escherichia coli glutaredoxin: Comparison with reduced E. coli glutaredoxin and functionally related proteins. Protein Sci. 1 (1992) 310-321
199. Yao K.-S., Clayton M., and O'Dwyer P.J. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J. Natl. Cancer Inst. 87 (1995) 117-122
200. Yao K.S., and O'Dwyer P.J. Specific induction of Jun binding to the AP-1 response element of DT diaphorase in hypoxic HT29 colon adenocarcinoma cells. Proc. Am. Assoc. Cancer Res. 35 (1994) 3341
201. Yao K.-S., Xanthoudakis S., Curran T., and O'Dwyer P.J. Activation of AP-1 and of a nuclear redox factor, ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14 (1994) 5997-6003
202. Yodoi J., and Tursz T. ADF, a growth-promoting factor dervied from adult T cell leukemia and homologous to thioredoxin: Involvement in lymphocyte immortalization by HTLV-1 and EBV. Adv. Cancer Res. 57 (1991) 381-411
203. Zhang W.-W., and Yaneva M. Reduced sulphydryl groups are required for DNA binding of KU protein. Biochem. J. 293 (1993) 769-774
204. Ziegler D.M. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu. Rev. Biochem. 54 (1985) 305-329